Cyamemazine

氰美马嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCyamemazine
Drug Alias Name氰甲丙嗪氰马美嗪腈异丁嗪TercianRP-7204 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsMental Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFrance
Original Approved Date1972/01/01
Country/TerritoryFrance
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsMental Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN05AA06
Related LinksWikipediaDrugBankKEGG